SCIMEDX PHASE II ANTI-PR3 ANTIBODY EIA (1282)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II ANTI-PR3 ANTIBODY EIA medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-proteinase-3 (Pr-3) antibodies (K010287 | K010287) HIGH
Effective Date: 2001-03-28

Other General Immunology Devices:

Medical DeviceComplexity
Seimens, ADVIA 1800View Complexity
BEHRING NEPHELOMETER IIView Complexity
Abbott ARCHITECT I SystemView Complexity
elias usa Varelisa SS-B(La) AntibodiesView Complexity
GenBio ImmunoDOT Borrelia DotBlot M TestView Complexity
TOSOH AIA-600View Complexity
Diagnostic Products Corp. AlaSTAT Allergen Specific IgEView Complexity
Quest International Triturus� CMV IgGView Complexity
EUROIMMUN Anti-PLA2R IFAView Complexity
Boehringer Mannheim Hitachi 705View Complexity